In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

Health technology company Royal Philips announced it received FDA 510 (k) clearance for its latest image-guided navigation ...

Learn how trained dogs use their powerful noses to identify volatile organic compounds linked to several types of cancer.

With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

Vitamin E and selenium are essential antioxidants that support immune function and protect against cell damage. Learn about their benefits, food sources, and supplements.

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Johnson & Johnson stands second among the most ...

EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.

Britain set out its plan to invest 1 billion pounds ($1.34 billion) in computing infrastructure to drive the development of ...